CD274 and ganglioneuroblastoma: Densities of the investigated immune biomarkers across all tumor indications, expressed as number of positive cells per square millimeter, are presented in Figure 3 along with corresponding DIA results for selected indications with highest and lowest values for PD‐L1 positivity, ganglioneuroblastoma and nephroblastoma respectively.